电视辅助胸腔镜手术与开放手术治疗I期胸腺上皮肿瘤:倾向评分匹配研究
基于中国胸腺瘤研究协作组(ChART)回顾性数据库,1994至2012年间1087例UICC病理I期胸腺上皮肿瘤手术患者中,电视辅助胸腔镜手术(VATS)271例(24.9%),开放手术816例(75.1%)。倾向评分匹配后每组110例,两组总生存、无病生存、累积复发率和重症肌无力改善率均无显著差异。
要点
- 倾向评分匹配后VATS组与开放手术组总生存(85.7% vs 93.1%,P=0.539)无显著差异。
- 匹配后两组无病生存(92.5% vs 91.9%,P=0.773)和累积复发率(7.1% vs 5.8%,P=0.522)无显著差异。
- 匹配后两组重症肌无力改善率(83.3% vs 88.2%,P=0.589)无显著差异。
核心结论
- 该倾向评分匹配研究提示,对于I期胸腺上皮肿瘤,VATS与开放手术的肿瘤学结局相似。
- 微创手术可能是早期胸腺恶性肿瘤可接受的手术方式。
研究设计与样本
- 基于中国胸腺瘤研究协作组(ChART)回顾性数据库的倾向评分匹配研究。
- 纳入1994年至2012年间接受手术的UICC病理I期胸腺上皮肿瘤患者共1087例。
- VATS组271例(24.9%),开放手术组816例(75.1%)。
- 按性别、重症肌无力、肿瘤大小、组织学分类、病理T分期、胸腺切除范围、辅助放疗和辅助化疗进行倾向评分匹配,每组110例。
主要发现
- 匹配前VATS组肿瘤较小(P=0.002)、组织学分级较低(P=0.034)、T分期较低(P<0.001)且辅助治疗较少(P<0.001)。
- 匹配后两组患者人口学特征、肿瘤特征或辅助治疗无显著差异,所有匹配患者均达R0切除。
- 单因素和多因素分析中,总生存、无病生存和累积复发率仅由WHO组织学预测,而非手术方式。
- 匹配后两组总生存(85.7% vs 93.1%,P=0.539)、无病生存(92.5% vs 91.9%,P=0.773)、累积复发率(7.1% vs 5.8%,P=0.522)和重症肌无力改善率(83.3% vs 88.2%,P=0.589)均无显著差异。
临床怎么用
- 原文结论提示,微创手术可能是早期胸腺恶性肿瘤可接受的手术方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Video-assisted thoracoscopic surgery (VATS) has been increasingly used in the management of thymic epithelial tumours. However, its oncological efficacy remains to be proved. The purpose of this study is to compare the oncological outcomes following thoracoscopic versus open surgery in the case-matched groups of patients with early-stage thymic tumours from the Chinese Alliance for Research in Thymomas (ChART) retrospective database. METHODS: Between 1994 and 2012, a total of 1087 patients who underwent surgery for UICC (Union for International Cancer Control) pathological Stage I tumours from the ChART retrospective database were recruited for this study. A propensity score-matched analysis was used to compare the long-term outcomes in patients who received VATS or open surgery. RESULTS: VATS resection was performed in 271 patients (24.9%) and open surgery in 816 patients (75.1%). Before propensity score matching, the VATS group had a smaller tumour size (P = 0.002), lower grade histology (P = 0.034), lower T stage (P < 0.001) and less adjuvant therapy (P < 0.001). Propensity score matching by gender, myasthenia gravis, tumour size, histological classification, pathological T stage, extent of thymectomy, adjuvant radiotherapy and adjuvant chemotherapy identified 110 patients in each group. After matching, there was no significant difference in patient demographics, tumour characteristics or adjuvant therapy. All matched patients had R0 resection. Overall survival, disease-free survival and cumulative incidence of recurrence were only predicted by WHO histology, but not by surgical approach, in both univariable and multivariable analyses. There was no significant difference in the overall survival (85.7% vs 93.1%, P = 0.539), disease-free survival (92.5% vs 91.9%, P = 0.773), cumulative incidence of recurrence (7.1% vs 5.8%, P = 0.522) and improvement rate of myasthenia gravis (83.3% vs 88.2%, P = 0.589) between the 2 groups. CONCLUSIONS: This propensity score-matched study suggests that VATS and open surgeries are associated with similar oncological outcomes for Stage I thymic epithelial tumours. Minimally invasive surgery might be an acceptable surgical approach for early-stage thymic malignancies.
引用
- Gu Z, Chen C, Wang Y, et al. Video-assisted thoracoscopic surgery versus open surgery for Stage I thymic epithelial tumours: a propensity score-matched study. Eur J Cardiothorac Surg. 2018. PMID: 30016438. doi:10.1093/ejcts/ezy239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。